Roadmap for HCC Surveillance and Management in the Asia Pacific
Cancers · 10.06.2025 · 17 (12) · 1928
DOI: 10.3390/cancers17121928 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 10.06.2025. Verfasst von Masatoshi Kudo und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Faculty of Medicine, Kindai University, Osaka 589-8511, Japan. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality, with the Asia-Pacific (APAC) region bearing a disproportionate burden. This paper examines HCC challenges within seven APAC health systems, identifies key barriers at each stage of the patient journey, and proposes tailored, actionable solutions. To effectively address HCC challenges, a stepwise approach should prioritise high-impact solutions, focusing on prevention, early diagnosis, and expanding surveillance to maximise health outcomes and economic benefits, while tailoring strategies to each health system’s unique resources and constraints.
Methods
A mixed-methods approach was used, including expert consultations from the 2024 HCC APAC Policy Forum, a literature review, and a review of Japan’s HCC management model. Data were collected through workshops and stakeholder feedback from healthcare professionals, policymakers, researchers and patient advocates across Australia, India, Malaysia, South Korea, Taiwan, Thailand, and Vietnam.
Results
Key findings include significant disparities in HCC awareness, prevention, early detection, diagnosis, and access to treatment. Common challenges across APAC include limited public awareness, suboptimal surveillance infrastructure, and financial barriers to care. The integration of novel biomarkers and advanced surveillance modalities were identified as crucial priorities for improving early detection. Japan’s multi-faceted approach to HCC management serves as a successful model for the region.
Conclusions
A customised and targeted approach is essential for reducing the HCC burden across APAC. The proposed recommendations, tailored to each health system’s needs, can significantly improve patient outcomes and reduce healthcare costs. Effective collaboration among stakeholders is necessary to drive these changes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Faculty of Medicine, Kindai University, Osaka 589-8511, Japan.
- Department of Epidemiology, National Cancer Hospital, Hanoi 100000, Vietnam.
- Genomics Research Center, Academia Sinica, Nangang District, Taipei City 115, Taiwan.
- Medical Profession & Officer Health Protection Division, Department of Medical Service Administration, Vietnam Ministry of Health, Hanoi 11110, Vietnam.
- Storr Liver Centre, Westmead Institute for Medical Research, University of Sydney, Sydney, NSW 2145, Australia.
- College of Medicine, Yonsei University, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea.
ORCID-Profile: Masatoshi Kudo, Bui Thi Oanh, Chien-Jen Chen, Jacob George, Do Young Kim, Sheng-Nan Lu, Teerha Piratvisuth
Zitieren
APA
Kudo, M., Oanh, B. T., Chen, C. J., Ngat, D. T., George, J., Kim, D. Y., Pimsawadi, L., Tangkijvanich, P., Pwu, R. F., Mohamed, R., Bunnag, S., Lu, S. N., Kudtiyakarn, S., Kanto, T., Piratvisuth, T., Wu, C. C., Sarno, R., & APAC Liver Disease Alliance (2025). Roadmap for HCC Surveillance and Management in the Asia Pacific. Cancers, 17(12), 1928. https://doi.org/10.3390/cancers17121928
Vancouver
Kudo M, Oanh BT, Chen CJ, Ngat DT, George J, Kim DY, et al. Roadmap for HCC Surveillance and Management in the Asia Pacific. Cancers. 2025;17(12):1928. doi:10.3390/cancers17121928
BibTeX
@article{Kudo2025,
author = {Kudo, Masatoshi and Oanh, Bui Thi and Chen, Chien-Jen and Ngat, Do Thi and George, Jacob and Kim, Do Young and Pimsawadi, Luckxawan and Tangkijvanich, Pisit and Pwu, Raoh-Fang and Mohamed, Rosmawati and Bunnag, Sakarn and Lu, Sheng-Nan and Kudtiyakarn, Sirintip and Kanto, Tatsuya and Piratvisuth, Teerha and Wu, Chao-Chun and Sarno, Roberta and APAC Liver Disease Alliance, APAC Liver Disease Alliance},
title = {Roadmap for HCC Surveillance and Management in the Asia Pacific},
journal = {Cancers},
year = {2025},
volume = {17},
number = {12},
pages = {1928},
doi = {10.3390/cancers17121928}
}
EUVIMED